Interestingly, contrasting downregulation was observed in kidney chromophobe carcinoma, thymoma, and thyroid carcinoma, suggesting a potential dual role of TIGD1, acting as an oncogene in certain cancers while exhibiting a tumor-suppressive function in others. This evidence concerns the gene TIGD1 and cancer.